期刊文献+

阿托伐他汀对急性冠状动脉综合征患者血红素氧合酶和Th细胞的影响

Eftect of Atorvastatin on Heme Oxygenase-1,and T Helper Cells of Patients with Acute Coronary Syndrome
下载PDF
导出
摘要 目的:探讨阿托伐他汀对急性冠脉综合征(ACS)患者血红素氧合酶-一氧化碳(HO-1/CO)系统、1型-2型辅助性T细胞(Thl/Th2)及其细胞因子(IFN-γ、IL-2、IL-4、IL-10)的影响。方法:207例ACS患者随机分为阿托伐他汀治疗组(104例)和对照组(103例),检测治疗前后外周血Thl/Th2频率及其相关细胞因子、HO-1、CO浓度及血脂等指标。结果:(1)两组治疗前后血脂水平变化均无显著性(P>0.05);(2)与治疗前及对照组比较,阿托伐他汀组Thl频率、IFN-γ、IL-2水平显著下降,而HO-1、CO和IL-10水平均显著升高(P<0.01),Th2(IL-4)频率差异无统计学意义(P>0.05)。结论:阿托伐他汀既能调节ACS患者Thl/Th2分化失衡,又能促进HO-1/CO系统表达,从而发挥免疫调节、抑制炎症反应、改善内皮功能等心血管保护作用。 Objective : To investigate the influence of atorvastatin on heme oxygenase-1/carbon monoxide (HO-1/CO) system and T helper cells (Th) and their cell factors of patients with acute coronary syndrome (ACS). Methods: Two hundred and seven patients with ACS were randomly divided into atorvastatin group and control group. Thl/Th2 cell frequencies, related cytokine concentrations in peripheral blood, and levels of HO-1, CO and lipid were detected before and after treatment of atorvastatin. Results: Lipid levels did not change significantly in the two groups (P 〉0. 05 ). Levels of HO-1, CO and IL-10 increased significantly, while Levels of IFN-γ and IL-2, and Thl cell frequency decreased significantly in atorvaststin group than these in the control group ( P 〈 0.01 ). There was not statistically significant difference of Th2 cell frequency between the two groups ( P 〉 0. 05 ). Conclusions: Atorvastatin could modulate imbalance of Thl/Th2, and promote expressions of HO-1 and CO as well, which can educe protective function to heart and blood vessels including immuno-modulating reaction, inflammation inhibit, and endothelial function improvement.
出处 《贵阳医学院学报》 CAS 2013年第1期27-30,34,共5页 Journal of Guiyang Medical College
基金 贵州省科技教育人才省长资金项目[黔科专合字(2007)72号] 贵州省科学基金资助项目[黔科合字(2006)2074号]
关键词 急性冠状动脉综合征 血红素氧合酶 一氧化氮 T淋巴细胞 阿托伐他汀 acute coronary syndrome heme oxygenase nitric oxide T-lymphocytes atorvastatin
  • 相关文献

参考文献17

  • 1Kinlay S , Selwyn AP, Delagrange D, et al . Biological mechanismsf or the clinical success of lipid-low ering in coronary artery disease and the use of surrogate end points [ J ]. Curr Opin Lipidol, 1996 (7) : 389 - 397.
  • 2GrosserN, ErdmannK, HemmerleA, et al. Rosuvastatin up- regulates the antioxidanst defensc protein heme oxygenase -1. Biochem Biophys Res [ J ]. Commun, 2004 ( 325 ) : 871 - 876.
  • 3Lee TSM, ChangCC, ZhuY, et al. Simvastatin induces heme oxygenase -1 A novd mechanism of vessel protection [ J ]. Circulation, 2004 ( 11 ) : 1296 - 1302.
  • 4Khallou-Laschet J, Caligiufi G, Gmyer E, et al. Nepmath- emgenic role of T ceils requires cell division and isdepen- dent on the stage of the disease [ J ]. Arterioacler Thromb Vase Biol,2006(26) : 353 -358.
  • 5Methe H,Brunner S,Wiegand D,et al. Enhanced T-help- er_l lymphocyte activation patterns in acute coronary syn- dromes[ J]. J Am Coil Cardiol,2005 (45) : 1939 - 1945.
  • 6韩淑芳,李晓燕,刘科卫,王琳,崔瑞,钱伟,卓展鹏,张安吉.急性冠状动脉综合征患者外周血中辅助性T细胞亚群失衡促进血管内皮细胞的损伤作用[J].中华心血管病杂志,2008,36(12):1070-1073. 被引量:2
  • 7刘科卫,李晓燕,韩淑芳,许琳,黄志刚,李长春.阿托伐他汀调节急性冠状动脉综合征患者外周血辅助性T细胞亚群失衡的研究[J].中华老年心脑血管病杂志,2010,12(2):120-122. 被引量:10
  • 8Braunward E, Antman EM, Beasley JW, et al. ACC/ AHA 2002 guideline update for management of patients with unstable angina and non-ST-segment elevation myo- cardial Infarction [ J ]. J Am Coil Cardiol, 2002 ( 7 ) : 1366 - 1374.
  • 9Tzong S L, Chieh C, Yi Zhu, et al. Simvastatin induces heme oxygenase-1 : A novel mechanism of vessel protec- tion [ J ]. Circulation, 2004 ( 110 ) : 1296 - 1302.
  • 10Heeba G, Moselhy ME, Hassan M, et al. Anti-athero- genic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1 [ J]. Br J Pharmacol,2009(156) : 1256 - 1260.

二级参考文献35

  • 1Binder C J, Chang M, Shaw P, ctal. Innate and acquired immunity in atherogenesis. Nat Med, 2002,8:1218-1226.
  • 2Getz GS. Thematic review series: the immune system and atherogenesis. Bridging the innate and adaptive immune systems. J Lipid Res, 2005, 46 : 1-10.
  • 3Hansson GK. Inflammation, atherosclemsis, and coronary artery disease. N Engl J Med, 2005,352:1685-1695.
  • 4Daugherty A, Rateri DL. T lymphocytes in atherosclerosis: the yin-yang of Thl and Th2 influence on lesion formation. Circ Res, 2002,90 : 1039-1040.
  • 5Khallou-Laschet J, Caligiuri G, Groyer E, et al. The proatherogenic role of T cells requires cell division and is dependent on the stage of the disease. Arterioscler Thromb Vasc Biol, 2006,26:353-358.
  • 6Elhage R, Gourdy P, Brouchet L, et al. Deleting TCR alpha beta + or CD4 + T lymphocytes leads to opposite effects on site-specific atherosclemsis in female apolipoprotein E-deficient mice. Am J Pathol,2004,165 : 2013-2018.
  • 7Nakajima T, Schulte S, Warrington KJ, et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation, 2002,105:570-575.
  • 8Liuzzo G, Gorozy JJ, Yang H, et al. Monoelonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation, 2000,102:2883-2888.
  • 9Methe H, Brunner S, Wiegand D, et al. Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. J Am Coil Cardiol, 2005 (45) : 1939-1945.
  • 10Potteaux S, Esposito B, van Oostrom O, et al. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Throm Vasc Biol, 2004,24 : 1474-1478.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部